Shares of Pharming Group NV (OTCMKTS:PHGUF – Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $1.70, but opened at $1.51. Pharming Group shares last traded at $1.51, with a volume of 1,000 shares trading hands.
Pharming Group Price Performance
The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.39 and a current ratio of 3.16. The company has a market cap of $1.01 billion, a P/E ratio of 151.15 and a beta of 0.42. The firm’s fifty day moving average is $1.78 and its two-hundred day moving average is $1.60.
About Pharming Group
Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.
Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.
Read More
- Five stocks we like better than Pharming Group
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Your name isn’t on our protected list yet
- Silver paying 20% dividend. Plus 68% share gains
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Pharming Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharming Group and related companies with MarketBeat.com's FREE daily email newsletter.
